联合模式包括妇科癌症中的新型增敏剂
Combined modality including novel sensitizers in gynecological cancers.
局部晚期妇科癌症的标准治疗主要依赖以铂类为基础的同步放化疗,随后进行近距离放疗。
46.9分
★★★☆☆
站内排序·非疗效
ALL SOURCES
Combined modality including novel sensitizers in gynecological cancers.
局部晚期妇科癌症的标准治疗主要依赖以铂类为基础的同步放化疗,随后进行近距离放疗。
Mechanisms of resistance to adoptive cell therapy with tumor-infiltrating lymphocytes.
TIL-ACT 在特定用途之外显示出前景,但其成功取决于能否克服由患者、肿瘤和产品因素驱动的耐药性。要提高其疗效,需要精细的患者选择、TIL 优化以及机制性见解,以指导新的、改进的治疗方法。
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。